Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas | MicrobiomeTrials← Back to trialsNCT07506161
Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas
CompletedOBSERVATIONAL
Trial Details
Start: 2021-09-09Est. Completion: 2025-12-31
Enrollment target: 27 participants Locations- Premier Med Egészségügyi- Oktató- és Kutatóintézet, Budapest, Hungary
Other microbiome trials you might be interested in
Thyroid Carcinoma
This study is to evaluate the effectiveness of nsPFA in treating papillary thyroid microcarcinoma. T
Sarasota, United StatesEst. completion Jan 31, 2029
Papillary Thyroid Microcarcinoma
Thyroid surgery has always been the mainstay of treatment for thyroid cancer. Thyroid surgery carries a low risk of comp…
New York, United StatesEst. completion Nov 2027